46,XX difference of sex development induced by exogenous maternal-derived androgen

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:325099
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

46,XX difference of sex development (DSD) induced by exogenous maternal-derived androgen is a rare condition in which a baby who is genetically female (having two X chromosomes, or 46,XX) is born with genitals that appear more masculine or ambiguous. This happens because the baby was exposed to unusually high levels of male-type hormones (androgens) during pregnancy, and these hormones came from the mother rather than from the baby's own body. Sources of excess maternal androgens can include certain medications the mother took during pregnancy (such as some older forms of progesterone or anabolic steroids), or rarely, hormone-producing tumors in the mother such as an ovarian or adrenal tumor. The degree of genital changes in the baby can vary widely. Some babies may have only mild enlargement of the clitoris, while others may have more significant changes such as partial fusion of the labial folds or a urogenital sinus (where the urethra and vagina share a common opening). Importantly, the internal reproductive organs — the uterus, fallopian tubes, and ovaries — are typically completely normal because the androgen exposure only affects the external genitals during a specific window of fetal development. Once the source of excess androgen is removed (for example, the mother stops taking the medication or the tumor is treated), no further masculinization occurs after birth. Treatment depends on the degree of genital changes and may include surgical correction if needed, hormone monitoring, and psychological support. With appropriate care, individuals with this condition generally have normal fertility and a normal life expectancy. The condition is also sometimes referred to as maternal androgen-induced virilization of a 46,XX fetus or exogenous androgen-induced female pseudohermaphroditism, though the latter term is now considered outdated.

Also known as:

Key symptoms:

Enlarged clitoris at birthAmbiguous-looking genitals in a newborn girlPartial fusion of the labia (outer genital folds)Single opening for the urethra and vagina (urogenital sinus)Normal internal female organs (uterus, ovaries, fallopian tubes)Normal female chromosomes (46,XX)No ongoing masculinization after birth once androgen source is removedPossible darkening of genital skin

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for 46,XX difference of sex development induced by exogenous maternal-derived androgen.

View clinical trials →

No actively recruiting trials found for 46,XX difference of sex development induced by exogenous maternal-derived androgen at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the 46,XX difference of sex development induced by exogenous maternal-derived androgen community →

No specialists are currently listed for 46,XX difference of sex development induced by exogenous maternal-derived androgen.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to 46,XX difference of sex development induced by exogenous maternal-derived androgen.

Search all travel grants →NORD Financial Assistance ↗

Community

Open 46,XX difference of sex development induced by exogenous maternal-derived androgenForum →

No community posts yet. Be the first to share your experience with 46,XX difference of sex development induced by exogenous maternal-derived androgen.

Start the conversation →

Latest news about 46,XX difference of sex development induced by exogenous maternal-derived androgen

No recent news articles for 46,XX difference of sex development induced by exogenous maternal-derived androgen.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Has congenital adrenal hyperplasia been completely ruled out as a cause?,What was the likely source of the androgen exposure during pregnancy?,Are my child's internal reproductive organs (uterus, ovaries) completely normal?,Is surgery recommended, and if so, what are the risks and benefits of operating now versus waiting?,Will my child go through normal puberty and have normal fertility?,Can you refer us to a psychologist experienced with differences of sex development?,Are there support groups or other families we can connect with?

Common questions about 46,XX difference of sex development induced by exogenous maternal-derived androgen

What is 46,XX difference of sex development induced by exogenous maternal-derived androgen?

46,XX difference of sex development (DSD) induced by exogenous maternal-derived androgen is a rare condition in which a baby who is genetically female (having two X chromosomes, or 46,XX) is born with genitals that appear more masculine or ambiguous. This happens because the baby was exposed to unusually high levels of male-type hormones (androgens) during pregnancy, and these hormones came from the mother rather than from the baby's own body. Sources of excess maternal androgens can include certain medications the mother took during pregnancy (such as some older forms of progesterone or anabo

How is 46,XX difference of sex development induced by exogenous maternal-derived androgen inherited?

46,XX difference of sex development induced by exogenous maternal-derived androgen follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does 46,XX difference of sex development induced by exogenous maternal-derived androgen typically begin?

Typical onset of 46,XX difference of sex development induced by exogenous maternal-derived androgen is neonatal. Age of onset can vary across affected individuals.